β-globin matrix attachment region improves stable genomic expression of the Sleeping beauty transposon

Journal of Cellular Biochemistry

Volumn 112, Issue 9, 2011, Pages 2361-2375

  Sjeklocha, Lucas ^a   Chen, Yixin ^a   Daly, Meghan C ^a   Steer, Clifford J ^a   Kren, Betsy T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

BOEC; Gene therapy; HUH 7 cells; Matrix attachment region; Sleeping beauty transposon

Indexed keywords

BETA GLOBIN; GREEN FLUORESCENT PROTEIN; PLASMID DNA; TRANSPOSASE;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA TRANSPOSITION; ENDOTHELIUM CELL; GENE CONSTRUCT; GENE EXPRESSION; GENE INSERTION; GENE MAPPING; HEPATOMA CELL; HUMAN; HUMAN CELL; MATRIX ATTACHMENT REGION; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; SLEEPING BEAUTY TRANSPOSON; TRANSGENE; TRANSPOSON;

BETA-GLOBINS; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA TRANSPOSABLE ELEMENTS; ENDOTHELIAL CELLS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HMGB1 PROTEIN; HUMANS; MATRIX ATTACHMENT REGIONS; PLASMIDS; PRIMARY CELL CULTURE; RECOMBINANT PROTEINS; TRANSFECTION; TRANSGENES; TRANSPOSASES;

SIMIAN VIRUS 40;

EID: 84860390327     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23159     Document Type: Article

References (56)

1. Baus J, Liu L, Heggestad AD, Sanz S, Fletcher BS,. 2005. Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol Ther 12: 1148-1156. (Pubitemid 41723049)
2. Berezney R, Coffey DS,. 1974. Identification of a nuclear protein matrix. Biochem Biophys Res Commun 60: 1410-1417.
3. Bode J, Kohwi Y, Dickinson L, Joh T, Klehr D, Mielke C, Kohwi-Shigematsu T,. 1992. Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255: 195-197.
4. Chen ZY, Riu E, He CY, Xu H, Kay MA,. 2008. Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol Ther 16: 548-556. (Pubitemid 351314995)
5. Ciuffi A,. 2008. Mechanisms governing lentivirus integration site selection. Curr Gene Ther 8: 419-429.
6. Cui Z, Geurts AM, Liu G, Kaufman CD, Hackett PB,. 2002. Structure-function analysis of the inverted terminal repeats of the Sleeping Beauty transposon. J Mol Biol 318: 1221-1235. (Pubitemid 34753993)
7. Daniel R, Smith JA,. 2008. Integration site selection by retroviral vectors: Molecular mechanism and clinical consequences. Hum Gene Ther 19: 557-568. (Pubitemid 351913525)
8. de Silva S, Lotta LT Jr, Burris CA, Bowers WJ,. 2010. Virion-associated co-factor HMGB1 facilitates transposition from the HSV/Sleeping Beauty amplicon vector platform. Hum Gene Ther 21: 1615-1622.
9. Dean DA, Dean BS, Muller S, Smith LC,. 1999. Sequence requirements for plasmid nuclear import. Exp Cell Res 253: 713-722. (Pubitemid 30003133)
10. Fiorini A, Gouveia Fde S, Fernandez MA,. 2006. Scaffold/Matrix Attachment Regions and intrinsic DNA curvature. Biochemistry (Mosc) 71: 481-488. (Pubitemid 43814008)
11. Geurts AM, Yang Y, Clark KJ, Liu G, Cui Z, Dupuy AJ, Bell JB, Largaespada DA, Hackett PB,. 2003. Gene transfer into genomes of human cells by the Sleeping Beauty transposon system. Mol Ther 8: 108-117. (Pubitemid 36939302)
12. Geurts AM, Hackett CS, Bell JB, Bergemann TL, Collier LS, Carlson CM, Largaespada DA, Hackett PB,. 2006. Structure-based prediction of insertion-site preferences of transposons into chromosomes. Nucleic Acids Res 34: 2803-2811. (Pubitemid 43985641)
13. Gill DR, Pringle IA, Hyde SC,. 2009. Progress and prospects: The design and production of plasmid vectors. Gene Ther 16: 165-171.
14. Gluch A, Vidakovic M, Bode J,. 2008. Scaffold/matrix attachment regions (S/MARs): Relevance for disease and therapy. Handb Exp Pharmacol 186: 67-103.
15. Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES, Körner I, Gan L, Chen S, Castro-Obregon S, Hammermann R, Wolf J, Müller-Hartmann H, Nix M, Siebenkotten G, Kraus G, Lun K,. 2004. New non-viral method for gene transfer into primary cells. Methods 33: 151-163. (Pubitemid 38569660)
16. Harraghy N, Gaussin A, Mermod N,. 2008. Sustained transgene expression using MAR elements. Curr Gene Ther 8: 353-366.
17. Huang X, Haley K, Wong M, Guo H, Lu C, Wilber A, Zhou X,. 2010. Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells. Hum Gene Ther 21: 1577-1590.
18. Ivics Z, Izsvák Z,. 2004. Transposable elements for transgenesis and insertional mutagenesis in vertebrates: A contemporary review of experimental strategies. Methods Mol Biol 260: 255-276.
19. Ivics Z, Hackett PB, Plasterk RH, Izsvák Z,. 1997. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510. (Pubitemid 27508239)
20. Ivics Z, Katzer A, Stuwe EE, Fiedler D, Knespel S, Izsvák Z,. 2007. Targeted Sleeping Beauty transposition in human cells. Mol Ther 15: 1137-1144. (Pubitemid 46813616)
21. Izsvák Z, Ivics Z, Plasterk RH,. 2000. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 302: 93-102.
22. Jackson DA, Juranek S, Lipps HJ,. 2006. Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol Ther 14: 613-626. (Pubitemid 44480753)
23. Kim JM, Kim JS, Park DH, Kang HS, Yoon J, Baek K, Yoon Y,. 2004. Improved recombinant gene expression in CHO cells using matrix attachment regions. J Biotechnol 107: 95-105. (Pubitemid 38058671)
24. Kren BT, Ghosh SS, Linehan CL, Roy-Chowdhury N, Hackett PB, Roy-Chowdhury J, Steer CJ,. 2003. Hepatocyte-targeted delivery of Sleeping Beauty mediates efficient, inheritable gene transfer in vivo. Gene Ther Mol Biol 7: 231-240.
25. Kren BT, Yin W, Key NS, Hebbel RP, Steer CJ,. 2007. Blood outgrowth endothelial cells as a vehicle for transgene expression of hepatocyte-secreted proteins via Sleeping Beauty. Endothelium 14: 97-104. (Pubitemid 47386388)
26. Kren BT, Unger GM, Sjeklocha L, Trossen AA, Korman V, Diethelm-Okita BM, Reding MT, Steer CJ,. 2009. Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J Clin Invest 119: 2086-2099.
27. Lampela P, Elomaa M, Ruponen M, Urtti A, Mannisto PT, Raasmaja A,. 2003. Different synergistic roles of small polyethylenimine and Dosper in gene delivery. J Control Release 88: 173-183. (Pubitemid 36173962)
28. Lentacker I, Vandenbroucke RE, Lucas B, Demeester J, De Smedt SC, Sanders NN,. 2008. New strategies for nucleic acid delivery to conquer cellular and nuclear membranes. J Control Release 132: 279-288.
29. Li SD, Huang L,. 2006. Gene therapy progress and prospects: Non-viral gene therapy by systemic delivery. Gene Ther 13: 1313-1319. (Pubitemid 44323687)
30. Liu G, Aronovich EL, Cui Z, Whitley CB, Hackett PB,. 2004. Excision of Sleeping Beauty transposons: Parameters and applications to gene therapy. J Gene Med 6: 574-583. (Pubitemid 40228073)
31. Liu G, Geurts AM, Yae K, Srinivasan AR, Fahrenkrug SC, Largaespada DA, Takeda J, Horie K, Olson WK, Hackett PB,. 2005. Target-site preferences of Sleeping Beauty transposons. J Mol Biol 346: 161-173. (Pubitemid 40128313)
32. Mates L, Chuah MK, Belay E, Jerchow B, Manoj N, Acosta-Sanchez A, Grzela DP, Schmitt A, Becker K, Matrai J, Ma L, Samara-Kuko E, Gysemans C, Pryputniewicz D, Miskey C, Fletcher B, Vandendriessche T, Ivics Z, Izsvák Z,. 2009. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41: 753-761.
33. Mikkelsen JG, Yant SR, Meuse L, Huang Z, Xu H, Kay MA,. 2003. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Mol Ther 8: 654-665. (Pubitemid 37321695)
34. Miller AM, Dean DA,. 2008. Cell-specific nuclear import of plasmid DNA in smooth muscle requires tissue-specific transcription factors and DNA sequences. Gene Ther 15: 1107-1115.
35. Molto E, Fernandez A, Montoliu L,. 2009. Boundaries in vertebrate genomes: Different solutions to adequately insulate gene expression domains. Brief Funct Genomic Proteomic 8: 283-296.
36. Muller K, Heller H, Doerfler W,. 2001. Foreign DNA integration. Genome-wide perturbations of methylation and transcription in the recipient genomes. J Biol Chem 276: 14271-14278.
37. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J,. 1982. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42: 3858-3863. (Pubitemid 12054507)
38. Plasterk RH, Izsvák Z, Ivics Z,. 1999. Resident aliens: The Tc1/mariner superfamily of transposable elements. Trends Genet 15: 326-332. (Pubitemid 29343731)
39. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML,. 2003. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80: 148-158. (Pubitemid 37272241)
40. Schaffert D, Wagner E,. 2008. Gene therapy progress and prospects: Synthetic polymer-based systems. Gene Ther 15: 1131-1138.
41. Trembley JH, Ebbert JO, Kren BT, Steer CJ,. 1996. Differential regulation of cyclin B1 RNA and protein expression during hepatocyte growth in vivo. Cell Growth Differ 7: 903-916. (Pubitemid 26360730)
42. Vercammen E, Staal J, Beyaert R,. 2008. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 21: 13-25. (Pubitemid 351160008)
43. Vigdal TJ, Kaufman CD, Izsvák Z, Voytas DF, Ivics Z,. 2002. Common physical properties of DNA affecting target site selection of Sleeping Beauty and other Tc1/mariner transposable elements. J Mol Biol 323: 441-452. (Pubitemid 35283672)
44. Walisko O, Schorn A, Rolfs F, Devaraj A, Miskey C, Izsvák Z, Ivics Z,. 2008. Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol Ther 16: 359-369. (Pubitemid 351168045)
45. Williams DA,. 2008. Sleeping Beauty vector system moves toward human trials in the United States. Mol Ther 16: 1515-1516.
46. Wilson MH, Kaminski JM, George AL Jr. , 2005. Functional zinc finger/Sleeping Beauty transposase chimeras exhibit attenuated overproduction inhibition. FEBS Lett 579: 6205-6209. (Pubitemid 41546269)
47. Wong SP, Argyros O, Coutelle C, Harbottle RP,. 2009. Strategies for the episomal modification of cells. Curr Opin Mol Ther 11: 433-441.
48. + hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 114: 1319-1330.
49. Yant SR, Ehrhardt A, Mikkelsen JG, Meuse L, Pham T, Kay MA,. 2002. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat Biotechnol 20: 999-1005.
50. Yant SR, Park J, Huang Y, Mikkelsen JG, Kay MA,. 2004. Mutational analysis of the N-terminal DNA-binding domain of Sleeping Beauty transposase: Critical residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol 24: 9239-9247. (Pubitemid 39313924)
51. Yant SR, Wu X, Huang Y, Garrison B, Burgess SM, Kay MA,. 2005. High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol 25: 2085-2094. (Pubitemid 40354609)
52. Young JL, Benoit JN, Dean DA,. 2003. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature. Gene Ther 10: 1465-1470. (Pubitemid 36987140)
53. Zayed H, Izsvák Z, Khare D, Heinemann U, Ivics Z,. 2003. The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acids Res 31: 2313-2322. (Pubitemid 37442099)
54. Zayed H, Izsvák Z, Walisko O, Ivics Z,. 2004. Development of hyperactive Sleeping Beauty transposon vectors by mutational analysis. Mol Ther 9: 292-304. (Pubitemid 38256555)
55. Zhu J, Kren BT, Park CW, Bilgim R, Wong PY, Steer CJ,. 2007. Erythroid-specific expression of β-globin by the Sleeping Beauty transposon for sickle cell disease. Biochemistry 46: 6844-6858. (Pubitemid 46906414)
56. Zhu J, Park CW, Sjeklocha L, Kren BT, Steer CJ,. 2010. High-level genomic integration, epigenetic changes, and expression of Sleeping Beauty transgene. Biochemistry 49: 1507-1521.